What is Febuxostat Tablets 40mg Febutaz used for?
Febuxostat Tablets 40mg Febutaz belongs to the xanthine oxidase inhibitor class of drugs. It works by reducing the body’s production of uric acid. Febuxostat is a medicine that is used to prevent gout attacks but not to treat them.
When should you start taking febuxostat?
It’s better to take it first thing in the morning. Converse with your doctor, attendant, or drug specialist if you work or need to take your medication around dinner time. Febuxostat is a prescription that can be taken regardless of food. To stay away from gout attacks, take febuxostat consistently.
Is it possible to take Febuxostat Tablets 40mg Febutaz on a daily basis?
Febuxostat is taken once a day, with or without food, as a tablet. Using a glass of water, swallow the tablet. Your doctor will assist you in determining the appropriate dose.
What are the adverse effects of Febuxostat Tablets 40mg Febutaz?
- Pain in the arms, back, or jaw.
- Stools that are dark and tarry.
- A nasal bleed
- Pain or discomfort in the chest
- urine that is hazy
- decreased urine frequency or volume.
- I have diarrhea.
- Breathing that is laborious or labored.
For more click here.
Is Febuxostat Tablets 40mg Febutaz beneficial to the kidneys?
Febuxostat has been found to be safe and effective in individuals with moderate to severe renal impairment, and there is no need to change the dose in these cases.
What is the recommended dosage of Febuxostat Tablets 40mg Febutaz?
To avoid a gout attack, remember to take a febuxostat every day. It can take up to six months for it to fully take action. It has no impact during a gout attack, but you should continue to take it on a daily basis even if this happens.
Are Febuxostat Tablets toxic to the liver?
Although no cases of acute or chronic liver impairment have been recorded as a result of febuxostat, clinical experience with this drug is limited.
Is it possible that Febuxostat Tablets could cause renal damage?
According to study findings published in Arthritis Research & Therapy, Febuxostat and allopurinol are linked to an increased risk of acute kidney damage (AKI).
The absolute value of the drop in serum creatinine in the febuxostat group was minimal (0.03 mg/dL), despite the fact that it was much lower. Given the short duration of the trial, more prolonged suppression could have resulted in more change.